Markers of gluten sensitivity and celiac disease in bipolar disorder

Bipolar Disorders

Volumn 13, Issue 1, 2011, Pages 52-58

  Dickerson, Faith ^a   Stallings, Cassie ^a   Origoni, Andrea ^a   Vaughan, Crystal ^a   Khushalani, Sunil ^a   Alaedini, Armin ^b   Yolken, Robert ^c  

^a Stanley Research Center at Sheppard Pratt   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Celiac disease; Gliadin antibody; Gluten sensitivity

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; GLIADIN; GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LITHIUM; MARKER; MOOD STABILIZER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ANTIBODY RESPONSE; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; CELIAC DISEASE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS;

ADULT; ANTIBODIES; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CELIAC DISEASE; FEMALE; GENOTYPE; GLIADIN; HLA-DQ ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 79951506498     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2011.00894.x     Document Type: Article

References (30)

1. O'Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 2006; 90: 263-267.
2. Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ. Immunologic variables in acute mania of bipolar disorder. Neuroimmunol 2004; 150: 116-122.
3. Dickerson F, Stallings C, Origoni A et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 2010; 68: 101-104.
4. Dohan FC, Martin L, Grasberger JC, Boehme D, Cottrell JC. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol Psychiatry 1972; 5: 127-137.
5. Reichelt KL, Landmark J. Specific IgA antibody increases in schizophrenia. Biol Psychiatry 1995; 37: 410-413.
6. Cascella NG, Kryszak D, Bhatti B et al. Prevalence of celiac disease and gluten sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study population. Schizophr Bull 2011; 37: 94-100.
7. Sapone A, Lammers KM, Mazzarella G et al. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 2010; 152: 75-80.
8. Mothes T. Deamidated gliadin peptides as targets for celiac disease-specific antibodies. Adv Clin Chem 2007; 44: 35-63.
9. Dohan FC. Coeliac disease and schizophrenia. Lancet 1970; 1: 897-898.
10. Dohan FC. More on celiac disease as a model for schizophrenia. Biol Psychiatry 1983; 18: 561-564.
11. Eaton W, Mortensen PB, Agerbo E, Byrne M, Mors O, Ewald H. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ 2004; 328: 438-439.
12. West J, Logan RF, Hubbard RB, Card TR. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study. Aliment Pharmacol Ther 2006; 23: 71-74.
13. Ludvigsson JF, Osby U, Ekbom A, Montgomery SM. Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study. Scand J Gastroenterol 2007; 42: 179-185.
14. Peleg R, Ben-Zion ZI, Peleg A et al. "Bread madness" revisited: screening for specific celiac antibodies among schizophrenia patients. Eur Psychiatry 2004; 19: 311-314.
15. Samaroo D, Dickerson F, Kasarda DD et al. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 2010; 118: 248-255.
16. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, 1998.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press, 1994.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Non-patient Edition. (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute, 1998.
19. *0302 to aid diagnosis of celiac disease. J Immunol Methods 2006; 316: 125-132.
20. Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20: 310-319.
21. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
22. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
23. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
24. Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev 2008; 7: 644-650.
25. Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142: 289-298.
26. Volta U, Granito A, Parisi C et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010; 44: 186-190.
27. Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001; 47: 2023-2028.
28. Parizade M, Bujanover Y, Weiss B, Nachmias V, Shainberg B. Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol 2009; 16: 1576-1582.
29. th Annual Meeting of the Psychoneuroimmunology Research Society, Dublin, 2-5 June 2010.
30. Severance EG, Dickerson FB, Halling M et al. Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res 2010; 118: 240-247.